MLICM
CVAC

Metropolitan Life Insurance Company (MetLife)’s CureVac CVAC Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,534
Closed -$121K – 2349
2021
Q4 		$121K Sell
3,534
-27
-0.8% -$1.09K ﹤0.01% 2363
2021
Q3 		$195K Buy
+3,561
New +$215K ﹤0.01% 2091

Other funds holding CVAC

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s CVAC Position: Q1 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of CureVac (CVAC) in Q1 2022, closing a stake of 3,534 shares — an estimated $121K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CVAC in Q3 2021 and held it in 2 quarters. The position peaked at $195K in Q3 2021. 111 funds tracked by Wall St. Rank hold CVAC as of Q1 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining CureVac position as of Q1 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 3,534 CureVac shares in Q1 2022, an estimated $121K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in CureVac in Q3 2021 and held it in 2 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s CureVac position peaked at $195K in Q3 2021.
  • 111 funds tracked by Wall St. Rank held CureVac as of Q1 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.